BHC Stock Overview
Operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bausch Health Companies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.17 |
| 52 Week High | US$15.43 |
| 52 Week Low | US$5.45 |
| Beta | 0.74 |
| 11 Month Change | 0% |
| 3 Month Change | 38.76% |
| 1 Year Change | 19.34% |
| 33 Year Change | -64.87% |
| 5 Year Change | -70.23% |
| Change since IPO | 1,748.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| BHC | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -6.8% | -6.9% | 2.2% |
| 1Y | 19.3% | -22.8% | 23.4% |
Return vs Industry: BHC exceeded the Canadian Pharmaceuticals industry which returned -23.2% over the past year.
Return vs Market: BHC underperformed the Canadian Market which returned 23.4% over the past year.
Price Volatility
| BHC volatility | |
|---|---|
| BHC Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: BHC has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: BHC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20,270 | Tom Appio | www.bauschhealth.com |
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
Bausch Health Companies Inc. Fundamentals Summary
| BHC fundamental statistics | |
|---|---|
| Market cap | CA$4.10b |
| Earnings (TTM) | -CA$248.80m |
| Revenue (TTM) | CA$13.24b |
0.3x
P/S Ratio-16.5x
P/E RatioIs BHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BHC income statement (TTM) | |
|---|---|
| Revenue | US$9.47b |
| Cost of Revenue | US$2.76b |
| Gross Profit | US$6.71b |
| Other Expenses | US$6.89b |
| Earnings | -US$178.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.48 |
| Gross Margin | 70.87% |
| Net Profit Margin | -1.88% |
| Debt/Equity Ratio | -8,887.2% |
How did BHC perform over the long term?
See historical performance and comparison